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Abstract
Background: Fruit flies and mammals protect themselves against infection by mounting immune and metabolic
responses that must be balanced against the metabolic needs of the pathogens. In this context, p38 mitogen-activated
protein kinase (MAPK)-dependent signaling is critical to regulating both innate immunity and metabolism during
infection. Accordingly, we asked to what extent the Asian malaria mosquito Anopheles stephensi utilizes p38 MAPK
signaling during infection with the human malaria parasite Plasmodium falciparum.
Methods: A. stephensi p38 MAPK (AsP38 MAPK) was identified and patterns of signaling in vitro and in vivo (midgut) were
analyzed using phospho-specific antibodies and small molecule inhibitors. Functional effects of AsP38 MAPK inhibition
were assessed using P. falciparum infection, quantitative real-time PCR, assays for reactive oxygen species and survivorship
under oxidative stress, proteomics, and biochemical analyses.
Results: The genome of A. stephensi encodes a single p38 MAPK that is activated in the midgut in response to parasite
infection. Inhibition of AsP38 MAPK signaling significantly reduced P. falciparum sporogonic development. This phenotype
was associated with AsP38 MAPK regulation of mitochondrial physiology and stress responses in the midgut epithelium, a
tissue critical for parasite development. Specifically, inhibition of AsP38 MAPK resulted in reduction in mosquito protein
synthesis machinery, a shift in glucose metabolism, reduced mitochondrial metabolism, enhanced production of
mitochondrial reactive oxygen species, induction of an array of anti-parasite effector genes, and decreased resistance to
oxidative stress-mediated damage. Hence, P. falciparum-induced activation of AsP38 MAPK in the midgut facilitates
parasite infection through a combination of reduced anti-parasite immune defenses and enhanced host protein synthesis
and bioenergetics to minimize the impact of infection on the host and to maximize parasite survival, and ultimately,
transmission.
Conclusions: These observations suggest that, as in mammals, innate immunity and mitochondrial responses are
integrated in mosquitoes and that AsP38 MAPK-dependent signaling facilitates mosquito survival during parasite
infection, a fact that may attest to the relatively longer evolutionary relationship of these parasites with their invertebrate
compared to their vertebrate hosts. On a practical level, improved understanding of the balances and trade-offs between
resistance and metabolism could be leveraged to generate fit, resistant mosquitoes for malaria control.
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Background
The biological complexity of the malaria parasite life
cycle has made it an elusive target for drug and vaccine
development. This has led to the re-emergence and
further spread of this disease, with over 250 million new
cases of malaria occurring annually [1]. The malaria
parasite life cycle involves development and transmission
by Anopheles mosquitoes. Plasmodium development in
Anopheles begins with ingestion by the mosquito of
blood containing male and female gametocytes; these
fuse within minutes of ingestion to form mobile ooki-
netes that penetrate the midgut epithelium 24-36 h later
and rapidly transform into vegetative oocysts. After
growth and development for 10-12 days (the extrinsic
incubation period or EIP), hundreds to thousands of
sporozoites are released from each oocyst into the
hemolymph, the open circulatory system of the mos-
quito. These sporozoites invade the salivary glands,
where they are released into the saliva and injected into
a human host during subsequent blood feeding. As para-
sites undergo these developmental transitions, they are
simultaneously exposed to physical, chemical, and im-
mune barriers of the mosquito that act to limit infection
[2, 3]. Chemical barriers of the midgut, such as increased
reactive nitrogen and oxygen species (RNOS) can kill
parasites directly in the gut lumen, preventing contact
between parasites and the epithelium [4–9]. Additional
immune defenses are activated when parasites encounter
the midgut epithelium and include the production of im-
mune effectors such as TEP1 [10, 11], APL1 [12, 11, 13],
LRIM1 [14, 11], and LRRD7 [15], which together func-
tion to further limit parasite development. For successful
infection, ookinetes must traverse the midgut by migra-
tion through or between midgut epithelial cells [16];
therefore, the integrity of the physical barrier of the mid-
gut epithelial can also limit parasite development [7].
Mitogen-activated protein kinases (MAPKs) are serine/
threonine protein kinases that regulate a variety of cellular
processes. The three main families of MAPKs are the
extracellular signal-regulated kinases (ERKs), c-Jun N-
terminal kinases (JNKs) and p38 MAPKs (reviewed in
[17]). P38 MAPK is highly conserved and critical to innate
immune responses in a variety of organisms [18–21]. In
mammals, four p38 MAPK isoforms can be activated by
bacterial, viral, and parasitic stimuli (reviewed in [22]).
Caenorhabditis elegans has a single p38 MAPK ortholog
(PMK-1) that regulates antimicrobial peptide expression
(reviewed in [21]). In Drosophila melanogaster, two p38
MAPK orthologs (p38a and p38b) participate in the host
immune response to bacterial and fungal stimuli [19],
while Aedes mosquitoes encode a single p38 MAPK that
is involved in innate immune responses to bacterial patho-
gens [23–25]. The midgut/intestine is a central tissue for
p38 MAPK regulation in both D. melanogaster [26–28]
and in C. elegans [29, 30], where this pathway regulates
gut homeostasis and immunity. The Anopheles gambiae
[31] and Anopheles stephensi genomes each encode a sin-
gle p38 MAPK, described herein, with associated pathway
signaling proteins [31]. Based on collective observations
from other species and the conservation of this pathway,
we hypothesized that p38 MAPK signaling contributes to
regulation of the response of Anopheles mosquitoes to
midgut development of Plasmodium parasites [32].
In addition to regulating the innate immune response,
p38 MAPK signaling also plays an important role in the
coordination of cellular stress responses [33, 34]. For ex-
ample, members of the MAPK family, including p38
MAPK, can be activated by reactive oxygen species (ROS)
[31, 35, 36]. While high levels of ROS can be detrimental
to the host and invading organisms, moderate levels of
ROS can act as signaling mediators in a number of bio-
logical processes including both innate and adaptive im-
munity [37–39]. In D. melanogaster, ROS-activated p38
MAPK induces the expression of the antioxidant manga-
nese superoxide dismutase (SOD2) [38], while in mammals
activation of p38 MAPK by ROS increases expression of
the antioxidants catalase and SOD [40]. In these organ-
isms, the production of antioxidants acts to attenuate the
molecular damage and cell death that high levels of ROS
can cause and ultimately feeds back to inhibit p38 MAPK
activity. However, in mosquitoes, high levels of ROS are
not only detrimental to the host but also to invading or-
ganisms such as malaria parasites [8, 41, 42], indicating
that a p38 MAPK-induced decrease in ROS could be bene-
ficial to both host survival and parasite development. In
addition, a number of studies have shown that ROS and
NO can regulate activity of inflammatory signaling path-
ways including those that are dependent on nuclear factor
(NF)-κB [43, 44], suggesting that p38 MAPK signaling
could also alter ROS-dependent induction of NF-κB-
dependent anti-malarial immune genes. Although we have
previously shown that p38 MAPK can be activated by ROS
in Anopheles midgut [31, 35], the downstream effects of
this activation on mosquito biology remain unclear.
Activation of p38 MAPK has also been associated with
increased protein translation via enhanced phosphoryl-
ation of MAPK-activated kinase 2 (MK2), which can
increase mRNA stability and translation. In particular,
MK2 abrogates mRNA instability caused by the presence
of AU-rich elements in the 3'-untranslated region of
transcripts [45–48]. In addition, p38 MAPK activation in-
creases peroxisome proliferator-activated receptor gamma
coactivator-1α (PGC-1α) phosphorylation and PGC-1β
expression [48, 49]. PGC-1α and PGC-1β belong to a fam-
ily of coactivator proteins that are highly responsive to en-
vironmental cues, such as temperature and nutritional
status, and that regulate the maintenance of glucose, lipid,
and energy (reviewed in [49]). In mammals, PGC-1α and
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PGC-1β regulate mitochondrial biogenesis and oxida-
tive metabolism in a tissue- and trigger-specific manner
through coactivation of the peroxisome proliferator-
activated receptors [50, 51], estrogen-related receptors
[52], and nuclear respiratory factors [53]. In addition to
these functions, PGC-1α and PGC-1β regulate import-
ant aspects of metabolism and immunity. For example,
PGC-1α, under starvation, exercise or adaptive thermo-
genesis, is known to drive expression of the gluconeo-
genetic enzymes phosphoenolpyruvate carboxykinase
(PEPCK) and glucose-6-phosphatase (G6Pase), while
PGC-1β enhances fatty acid oxidation and adrenergic-
independent mitochondrial biogenesis, principally through
the activation of pyruvate kinase (PK) and the hexokinase
glucokinase [54–57]. In addition, PGC-1β has been rec-
ognized as a critical regulator of mammalian immune
function [58]. In particular, interferon (IFN)-γ-induced
activation of macrophage mitochondrial ROS for host
defense is regulated via activation of PGC-1β by the IFN-γ-
signal transducer and activator of transcription (STAT)-1
signaling cascade [59].
In D. melanogaster, the single PGC-1 ortholog Spargel
controls mitochondrial biogenesis and is a downstream ef-
fector of the insulin-target of rapamycin (TOR) nutrient
sensing signaling cascade, suggesting that PGC-1 control
of energy homeostasis and nutritional status are conserved
from insects to mammals [60–62]. Our previous studies
have implicated coordinated control of insulin/insulin-like
growth factor signaling (IIS)-dependent mitochondrial
biogenesis with inflammatory ROS and NO synthesis and
resistance to P. falciparum infection in A. stephensi [63].
The full spectrum of regulatory pathways, however, in the
fly – and in anopheline mosquitoes as well – that integrate
mitochondrial function and immunity is unknown. Col-
lectively, our work and published observations suggested
that a subset of these functions could be integrated by p38
MAPK signaling during the mosquito host response to in-
fection. In support of this hypothesis, we show here that
P. falciparum infection of A. stephensi enhances p38
MAPK activation in the midgut within 30 min of blood
feeding. Pharmacological inhibition of A. stephensi p38
(AsP38) MAPK signaling pathway yielded a significant de-
crease in P. falciparum development in the mosquito mid-
gut. This was most likely due to increased ROS and
enhanced immune gene expression observed within the
first 24 h following inhibition of AsP38 MAPK signaling.
Increased ROS levels can directly kill parasites and signal
anti-malarial immune gene expression. Concurrently,
AsP38 MAPK inhibition significantly reduced transcript
levels of PGC-1 as well as expression of mitochondrial
proteins related to ATP production, protein translation,
and antioxidants, including mitochondrial SOD (SOD2).
Functionally, inhibition of AsP38 MAPK enhanced mos-
quito sensitivity to paraquat-induced oxidative stress and
precipitated a shift to glycolytic metabolism even in the
absence of parasite infection. Collectively these data
suggest that AsP38 MAPK-dependent repression of
immunity to P. falciparum is associated with enhanced
mitochondrial biogenesis, oxidative phosphorylation
(OXPHOS), antioxidant biosynthesis, and protein
translation, which may help the mosquito to survive
parasite infection.
Methods
Identification of A. stephensi p38 MAPK
Anopheles gambiae p38 MAPK amino acid sequence [31]
was used as a query to identify the homologous full-
length coding sequence of the AsP38 MAPK sequence in
the February 2014 A. stephensi Indian strain assembly by
Basic Local Alignment Search Tool (BLAST) [64]. The
region with the best match and 1 kilobase of flanking se-
quence were retrieved. Encoded domain sequences were
confirmed by manual protein sequence alignments.
Putative translational start site of the assembled AsP38
MAPK encoding gene was predicted using the ExPASy
translate tool (web.expasy.org/translate/) and adherence
to Kozak consensus [65].
RNA was isolated from 30 midguts of non-blood fed,
female A. stephensi mosquitoes using TriZOL reagent
(Invitrogen) for RNA extraction. Contaminating DNA was
removed from the RNA samples using Turbo DNA-free
(Ambion) and cDNA was synthesized using the Super-
Script®III First-Strand Synthesis System (Invitrogen). Sam-
ple cDNAs were used to perform PCR using high fidelity
AccuPrime Taq DNA Polymerase (Invitrogen). Primers
were designed based on AsP38 MAPK sequence using Pri-
mer Express software (Applied Biosystems). The following
AsP38 MAPK specific primers were used: AsP38 MAPK
forward 5’-GTGTGTCCATCTGTTCCGTA-3’ and re-
verse 5’-TTACGCCTGCGGTTC- 3’ for both cloning and
sequencing.
Cell culture and luciferase reporter assays
ASE cells were maintained as previously described [35].
For AsP38 MAPK phosphorylation studies, ASE cells were
either treated with 1 μg/ml LPS alone or pretreated with
10 μM BIRB796, 10 μM SB203580, or an equivalent
volume of DMSO as a control for 2 h. Luciferase reporter
assays were performed using the Defensin1, Cecropin1,
and Gambicin promoter-reporter plasmids as previ-
ously described [35]. At 24 h post-transfection, cells
were treated with 100 μg/ml LPS (Sigma-Aldrich) or
2 μg/ml peptidoglycan (PGN, Escherichia coli K12)
with 0.1-10 μM BIRB796 or an equivalent volume of
DMSO as a control. Luciferase activity was measured
24 h post-LPS or PGN treatment with the Dual-Glo
system (Promega).
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Immunoblotting
Protein extracts were prepared, separated, and trans-
ferred to membranes as previously described [66]. Mem-
branes were blocked in 5 % nonfat dry milk (w/v) in
Tris-buffered saline (pH 7.0) containing 0.1 % Triton-
100 (TBS-T) for 1 h at room temperature. Membranes
were incubated at 4 °C overnight with the following:
1:2,500 rabbit anti-phospho-p38 MAPK antibody (Cayman
Chemical), 1:2,000 rabbit anti-phospho-MK2 antibody
(Abgent), or with 1:10,000 rabbit anti-GAPDH antibody
(Abcam) in 5 % non-fat dry milk in TBS-T. Anti-phospho-
p38 MAPK antibody and anti-phospho-MK2 antibody
were raised against mammalian proteins; peptide sequences
used to produce these monoclonal antibodies have greater
than 90 % identity to their counterparts in A. stephensi.
Membranes were washed three times for 5 min each in 1X
TBS-T and incubated with a 1:20,000 dilution of HRP-
conjugated goat anti-rabbit (Fab’)2 fragment (Cell Signaling
Technology) at 4 °C overnight. To reveal antibody-bound
proteins, membranes were incubated with SuperSignal
West Dura chemiluminescent reagent for 5 min and visual-
ized using the Kodak Image Station 4000MM Pro and
Carestream Molecular Imaging software (Carestream
Health). Levels of phospho-proteins in each treatment
were first normalized to total protein levels as determined
by GAPDH and then to the appropriate control group.
Mosquito rearing and experimental treatments
A. stephensi Liston (Indian strain) were reared and main-
tained at 27 °C and 80 % humidity. All mosquito rearing
and feeding protocols were approved and in accordance
with regulatory guidelines and standards set by the
Institutional Animal Care and Use Committee of the
University of California, Davis. For experimental treat-
ments, laboratory reared 3-5 day old female mosquitoes
were kept on water overnight and then allowed to feed
for 30 min on reconstituted human blood meals pro-
vided through a Hemotek Insect Feeding System (Dis-
covery Workshops).
P. falciparum culture and mosquito infection
For mosquito infection, cultures of P. falciparum strain
NF54 MCB (obtained from Sanaria, www.sanaria.com)
were grown as previously described [66]. Mosquitoes
were allowed to feed on day 15 mature gametocyte cul-
tures diluted with human RBCs and heat-inactivated hu-
man serum with or without the p38 MAPK inhibitors
0.1-10 μM SB203580 or 10 μM BIRB796. All treatments
were added to the diluted P. falciparum culture immedi-
ately prior to blood feeding. Protocols involving the culture
and handling of P. falciparum for mosquito feeding were
approved and in accordance with regulatory guidelines
and standards set by the Biological Safety Administrative
Advisory Committee of the University of California, Davis.
After 10 days, midguts from 50 mosquitoes with fully
developed eggs (to confirm complete engorgement) from
each group were dissected in PBS and stained with 0.1 %
mercurochrome for direct counting of P. falciparum
oocysts. Means of oocysts per midgut in each treatment
group were calculated from all dissected mosquitoes,
excluding zeros for mosquitoes that contained no oocysts.
P. falciparum growth assays
Aliquots of P. falciparum NF54 culture were synchronized
48 h prior to the assay as described [67] and then plated
in 96 well flat bottom plates in complete RPMI 1640 with
HEPES, hypoxanthine and 10 % heat inactivated human
serum. Parasites were treated with 1 or 10 μM SB203580
or BIRB796 or with an equivalent volume of DMSO dilu-
ent for 48 h in a candle jar in a 37 °C incubator. Infected
RBCs were quantified as previously described [66].
Quantitative real-time PCR of mRNA transcripts
For immune gene expression assays 3-5 day old A.
stephensi were fed a blood meal containing freeze-
thawed P. falciparum products (FTPP, preparation
described in [68]) supplemented with 10 μM BIRB796 or
an identical FTPP blood meal supplemented with an
equivalent volume of DMSO diluent as a control. A total
of 30 midguts at each time point were dissected and
homogenized in TriZOL reagent (Invitrogen) for RNA
extraction and contaminating DNA was removed from
the RNA samples using Turbo DNA-free (Ambion).
cDNA was synthesized from RNA samples using the
SuperScript®III First-Strand Synthesis System (Invitro-
gen). Relative expression levels for LRIM1, LRRD7, NOS,
TEP1, DEF1 and APL1 [68] were analysed with Maxima
SYBR green/ROX qPCR Master Mix (Fermentas Ther-
moScientific) on an ABI 7300 Sequence Detection Sys-
tem (Applied Biosystems). Expression levels were
calculated using the 2−ΔΔCt method relative to the
ribosomal protein s7 gene [9]. Data from biological repli-
cates with separate cohorts of mosquito were used for
statistical analysis.
Preparation of A. stephensi for LC-MS/MS
Midguts from a total of 100 3-5 day old female A. stephensi
fed with P. falciparum-infected blood and 10 μM BIRB796
or an identical infected blood meal supplemented with an
equivalent volume of DMSO (diluent) as a control were
collected 24 h post-blood feeding. Midgut samples were
then lysed (50 mM Tris pH 6.8, 2 % SDS, 5 % Glycerol,
1 mM DTT, 3X protease and phosphatase inhibitor cock-
tail (Thermo Scientific) on ice for 50 min and centrifuged
at 14,000 g/4 °C for 15 min. Protein concentrations in the
supernatant were determined by BCA protein assay kit
(Thermo Scientific) and 60 μg of total protein from each
sample was electrophoretically separated by SDS-PAGE
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electrophoresis, and cut into 10 pieces. The following pro-
cesses refer to the method in [63]. Specifically, when Scaf-
fold (version Scaffold 3.5.1, Proteome Software Inc.) was
used to validate MS/MS based peptide and protein identifi-
cations, peptide identifications were accepted if they could
be established at greater than 95.0 % probability as speci-
fied by the Peptide Prophet algorithm [69]. Protein identifi-
cations were accepted if they could be established at
greater than 99.0 % probability and contained at least 2
identified peptides. Protein probabilities were assigned by
the Protein Prophet algorithm [70]. Proteins that contained
similar peptides and could not be differentiated based on
MS/MS analysis alone were grouped to satisfy the princi-
ples of parsimony. Using the parameters above, the False
Discovery Rate (FDR) was calculated to be 0.3 % on the
protein level and 0 % on the peptide level for the A. gam-
biae search set and 0.3 % on the protein level and 0 % on
the peptide level for the A. stephensi search set [71]. Differ-
ential protein expression between BIRB796 and DMSO
treatments were calculated using the Fisher’s exact t-test
of the Scaffold program based on the total number of
assigned spectra per protein.
ROS assays
For detection of mitochondrial superoxide, groups of 50
(3-5 day old) female A. stephensi were held on water
overnight, then allowed to feed for 30 min on an ATP-
saline solution (150 mM NaCl, 10 mM NaHCO3 and
1 mM ATP) supplemented with equivalent volumes of
10 μM BIRB796 or DMSO as a control. Non-fed mos-
quitoes were removed at the end of 30 min. At 6 h post
feeding, two pools of 10 midguts for each treatment
were dissected and incubated in 150 μl of 5 μM Mito-
SOX Red (Molecular Probes-Life Technologies) in wells
of a 96-well plate. The plate was incubated in the dark
at room temperature for 30 min and then read at excita-
tion 485 nm and emission 560 nm (Hidex Chameleon,
LabLogic). Non-fed mosquito midguts were used to de-
fine baseline superoxide levels. Confocal images were
prepared from additional midguts from the same feeding
groups. For microscopy, midguts were mounted in Pro-
long Gold with DAPI (Molecular Probes), imaged using
an Olympus FV1000 confocal microscope (Olympus)
and processed using ImageJ [72] and Adobe Photoshop.
Experiments were replicated four times with separate
cohorts of mosquitoes.
For detection of midgut peroxides, 50 (3-5 day old)
female A. stephensi were held on water overnight, and
then allowed to feed for 30 min on an ATP-saline solu-
tion containing 2 mM paraquat (Sigma-Aldrich) supple-
mented with equivalent volumes of 10 μM BIRB796 or
DMSO as a control. Pools of 5 dissected midguts in
50 μL PBS (two per treatment) were homogenized by
brief sonication and centrifuged to pellet debris. Peroxide
levels were estimated in 20 μL of sample supernatant in
duplicate using the Pierce Quantitative Peroxide assay
kit per manufacturer’s instructions. Samples were in-
cubated for 20 min at room temperature prior to spec-
trophotometer reading. Peroxide assay experiments
were replicated three times with separate cohorts of
mosquitoes.
Oxidative stress survivorship assays
100 female 3-5 day old A. stephensi were kept on water
for 48 h, and then fed for 30 min on a saline/ATP
solution supplemented with 1 mM paraquat (Sigma-Al-
drich) and 10 μM BIRB796 or an equivalent volume of
DMSO as a control. Dead mosquitoes were removed
and counted from 8-72 h after feeding. The experiment
was replicated three times with separate cohorts of
mosquitoes.
Pyruvate and lactate quantification
For quantification of pyruvate and lactate, 300 midguts/
treatment were resuspended in 300 μl of ice-cold 5 %
PCA and homogenized on ice with 4 × 30 s strokes with a
hand homogenizer. The resulting suspension was centri-
fuged at 10,300 g for 5 min at 4 °C. The supernatants were
collected and neutralized with 65 μl of 1 M K2CO3 visual-
ized with 2.5 μl of 0.05 % methyl orange [73]. The neutral-
ized extracts were then used for the quantification of
pyruvate levels as described elsewhere [73], with minor
modifications [74]. The assay was performed at 37 °C with
50 μl of neutralized extract and 200 μl of a reaction
mixture consisting of 0.2 mM NADH in 0.2 M K2HPO4
(pH 8.0). The baseline was recorded at 340 nm for 3 min
and then again for 10 min upon addition of 0.5 U/ml
LDH. Levels of pyruvate were calculated using the NADH
molar extinction coefficient (ε340 = 6,220 M
−1 cm−1) and
expressed as pmol/midgut.
Lactate levels were evaluated as described in [74] in the
same neutralized supernatant used for pyruvate measure-
ments. Final reaction volume was 200 μl and the assay
was run at 37 °C. A total of 50 μl of midgut extract were
added to 100 μl of glycine hydrazine buffer (prepared
exactly as described in [73] and 1 mM NAD+. The base-
line was recorded at 340 nm for 3 min, followed by
addition of 2.5 U/ml LDH. Changes in absorbance were
recorded for 10 min and lactate levels were calculated
using the NADH molar extinction coefficient and
expressed as pmol/midgut. Both pyruvate and lactate
measurements were carried out in triplicate using a Tecan
Infinite M200 microplate reader. Calibration curves
carried out with sodium pyruvate and sodium lactate
(0-2 μM) showed a detection limit of 0.6 and 0.3 μM,
respectively, with a coefficient of variation < 3 %.
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Identification and characterization of A. stephensi PGC-1
BLAST analysis of the A. gambiae genome with the hu-
man PGC-1α gene sequence revealed AGAP004361 as
the highest similarity sequence, sharing the characterized
RNA recognition motif (RRM). A. stephensi ASTEI08687
is the ortholog of AGAP004361 as well as the ortholog
of D. melanogaster Spargel/PGC-1 [60]. The homology
between A. stephensi ASTEI08687 and Spargel is also
greater than that between Spargel and human PGC-1α.
Primers for A. stephensi ASTE002911 were designed
using Primer Express software (Applied Biosystems): for-
ward 5’-GGTGGTTCAAAGGCAAGTGT-3’ and reverse
5’-GCTTGTCTGGCTTGGCTATC-3’.
Midguts from A. stephensi fed with P. falciparum-in-
fected blood supplemented with 10 μM BIRB796 or an
equivalent volume of DMSO as a control were collected 6
and 24 h post-blood feeding. Midgut RNA was extracted
and cDNA was synthesized as described above. Relative
expression levels for AsPGC-1 were analysed with Maxima
SYBR green/ROX qPCR Master Mix (Fermentas Ther-
moScientific) on an ABI 7300 Sequence Detection System
(Applied Biosystems). Expression levels were calculated
using the 2−ΔΔCt method relative to the ribosomal protein
s7 gene [9]. Data from biological replicates with unique
and separate groups of mosquito were used for statistical
analysis.
Statistical analyses
For parasite infection studies, data from three independ-
ent experiments with separate cohorts of mosquitoes were
analysed for the main effects of experiment and treatment.
Infection levels in controls from these replicates were not
significantly different from one another (ANOVA), so
these data were combined for statistical analysis. Differ-
ences in prevalence of infection (the presence of at least
one oocyst in a dissected mosquito) between treatment
conditions were determined by Fisher's exact test. For
survival studies, the data were analyzed in GraphPad using
Log-rank (Mantel-Cox) and Gehan-Breslow-Wilcoxon
analysis. For all other data sets, significance was deter-
mined by Student’s t-test (alpha = 0.05) or with one-
way ANOVA followed by Bonferroni’s post-test for
multiple comparisons.
Results
Identification and characterization of A. stephensi
p38 MAPK
The A. gambiae p38 MAPK amino acid sequence [31]
was used as a query to identify and annotate the full-
length coding sequence of AsP38 MAPK (ASTEI06041).
As in A. gambiae, the AsP38 MAPK genomic sequence
spans seven exons and six introns (Fig. 1a), suggesting
the existence of an ancestral p38 MAPK that predates
the divergence of Anopheles spp. Full-length AsP38
MAPK mRNA is expressed in the midgut epithelium of
non-blood fed female A. stephensi (Fig. 1b). Across the
length of encoded sequence, AsP38 MAPK shares 74 %
identity with human and mouse p38 MAPKs (not
shown), allowing for the use of tools developed for
mammalian p38 MAPKs (e.g., monoclonal antibodies,
small molecule inhibitors) in our studies.
To determine whether AsP38 MAPK phosphorylation
and, hence, activation occurs in mosquito cells in response
to stimulus with pathogen-associated molecular patterns
(PAMPs), we used LPS as a prototypical bacterial PAMP
and PfPs as a malaria parasite-specific stimulus. LPS can
activate p38 MAPK signaling in the mosquito Aedes
aegypti [23] and in D. melanogaster [19, 20, 37], so we rea-
soned that LPS should increase AsP38 MAPK phosphoryl-
ation. Accordingly, immortalized A. stephensi embryonic
(ASE) cells were stimulated with 1 μg/ml LPS and AsP38
MAPK phosphorylation levels were measured over the
course of 24 h. LPS stimulation resulted in a significant
and rapid increase in phosphorylated AsP38 MAPK that
returned to levels not different from control by 30 min to
1 h after stimulation (Fig. 2a and 2b), confirming inducible
p38 MAPK phosphorylation in A. stephensi that was
analogous to that described in other organisms. In
addition, ASE cells were stimulated with purified soluble
P. falciparum products (PfPs, 36 parasite equivalents/cell)
to confirm that parasite products alone could induce the
AsP38 MAPK pathway. PfPs was prepared as previously
described [66] and tested negative for LPS contamination.
We observed a significant increase in phosphorylated
AsP38 MAPK levels at 5 min post stimulation in response
to PfPs that was reduced below control levels by 30 min
(Additional file 1), confirming that parasite products, in
the absence of LPS, can activate this pathway.
To determine whether AsP38 MAPK was activated in
vivo in response to malaria parasite infection, female
Fig. 1 Gene structure and expression of A. stephensi p38 MAPK.
(a) The A. stephensi p38 (AsP38) MAPK gene includes 7 exons (black
boxes; length in base pairs (bp) indicated), 6 introns, and spans
17,303 bp. (b) Total RNA was isolated and converted to cDNA from
30 dissected midguts from non-blood fed female A. stephensi. AsP38
MAPK-specific primers were used to amplify cDNA by conventional
PCR; molecular standards (bp) are shown on left
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A. stephensi were fed a blood meal containing P. falcip-
arum-infected red blood cells (RBCs) and midgut AsP38
phosphorylation levels were quantified at 30 min (imme-
diately after the 30 min feeding) and 3 h post-blood
feeding. The results revealed a significant increase in
AsP38 MAPK phosphorylation in mosquitoes fed P.
falciparum-infected RBCs at 30 min post-feeding com-
pared to mosquitoes fed RBCs alone that returned to
baseline within 3 h (Figs. 2c and 2d), a pattern that was
consistent with PfPs-induced AsP38 phosphorylation in
vitro (Additional file 1). Together, these results demon-
strated that AsP38 MAPK is activated in the mosquito
midgut in response to P. falciparum infection.
Inhibition of AsP38 MAPK abolished phosphorylation of
MAPK-activated kinase 2 (MK2) in vitro and in vivo
MAP kinase-activated protein kinase 2 (MK2) is a pri-
mary downstream kinase target of p38 MAPK and is
commonly used to confirm p38 MAPK activity. Studies
in mammals have confirmed that activated MK2 medi-
ates p38 MAPK-dependent stabilization and efficient
translation of short-lived mRNAs (reviewed in [75]).
Highly homologous MK2 proteins are encoded in the A.
gambiae (AGAP011890) and A. stephensi (ASTEI05089)
genomes, suggesting that a conserved p38 MAPK-MK2
pathway exists in these species. To establish that MK2 is
a conserved target of AsP38 MAPK activation, we
selected the commonly used p38 MAPK small molecule
inhibitors SB203580 [76] and BIRB796 [77]. Unlike
SB203580, which directly competes with ATP binding to
block kinase activity, BIRB796 induces a conformational
change in p38 MAPK making it incompatible with ATP-
binding and abolishing its kinase activity [78]. The resi-
dues in the active site of p38 MAPK that are necessary
for BIRB796 binding are 100 % conserved in A. stephensi
[78], as is the ATP binding site that SB203580 interacts
with (not shown) [79]. BIRB796 also blocks p38 MAPK
phosphorylation and p38 MAPK nuclear localization that
occurs in response to DNA damage [80]. We used
SB203580 and BIRB796 side-by-side in a number of assays
to confirm targeting of AsP38 MAPK (and lack of an ef-
fect on P. falciparum growth, see below), but carried for-
ward with BIRB796 in our remaining assays because of its
minimal off-target effects [78] at the concentrations used
in this study.
Treatment with either SB203580 or BIRB796 com-
pletely abrogated MK2 phosphorylation in ASE cells in
vitro in response to 1 μg/ml LPS (Fig. 3a), establishing
the efficacy of these small molecule inhibitors for use in
A. stephensi and confirming that MK2 is a phosphoryl-
ation target of AsP38 MAPK during PAMP activation.
Based on the different modes of action of these inhibi-
tors, these results also confirmed that the observed
effects were not influenced by local concentrations of
ATP that may have obscured the inhibition pattern of
AsP38 MAPK. Provision of SB203580 and BIRB796 in a
Fig. 2 Phosphorylation of AsP38 MAPK increased in response to LPS in vitro and to P. falciparum infection in vivo. (a, c) Cell lysates from ASE cells
treated with 1 μg/ml LPS were collected at the indicated time points post-treatment and levels of phosphorylated p38 MAPK (pP38) were determined
by western blotting. Graph in (a) represents average fold change ± SEMs of pP38 protein levels normalized to untreated controls, n = 3-4. GAPDH
provided an assessment of protein loading. Pairwise comparisons of treatments versus controls at each time point were analysed by Student’s t-test,
significant p-values are shown. (c) is a representative western blot. (b, d) Midgut cell lysates from 3-5 day old female A. stephensi mosquitoes fed
uninfected or P. falciparum-infected blood were collected at 30 min and 3 h post feeding and levels of pP38 were determined by western blotting.
Graph in (b) represents average fold change ± SEMs of pP38 protein levels normalized to uninfected blood fed controls, n = 3. Dotted line represents
pP38 levels in uninfected blood fed controls. Pairwise comparisons of treatments versus controls at each time point were analysed by Student’s t-test,
significant p-values relative to control are shown. (d) is a representative western blot
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P. falciparum-infected blood meal reproducibly reduced,
but did not completely inhibit, MK2 phosphorylation in
the A. stephensi midgut at 2 h after feeding (Fig. 3b).
Inhibition of AsP38 MAPK decreased P. falciparum
development in A. stephensi
Having confirmed that AsP38 MAPK is activated by P.
falciparum infection, we sought to determine the impact
of AsP38 MAPK-dependent signaling on P. falciparum
development in the mosquito. Female A. stephensi mos-
quitoes were provided identical infectious blood meals
enriched with P. falciparum gametocytes that were sup-
plemented with 0.1-10 μM SB203580, 10 μM BIRB796,
or with an equivalent volume of DMSO as a diluent
control and the number of oocysts per midgut were
quantified at 10 days post-blood feeding. Two-way
ANOVA for each inhibitor indicated no significant dif-
ferences in control infection levels among replicates,
thus data from the replicates were combined for analysis.
Treatment with 10 μM SB203580 resulted in a 70 %
decrease in infection intensity from 14.3 to 4.3 oocysts
per midgut (Fig. 4a). Prevalence of infection (the pres-
ence of at least one oocyst in a dissected mosquito)
decreased significantly from 85 % to 60 % following
treatment with 10 μM SB203580 (Fig. 4b). Treatment of
mosquitoes provided infectious blood meals supple-
mented with 10 μM BIRB796 also yielded significant
reductions in infection intensity and prevalence (Fig. 4c
and 4d). These data suggested that AsP38 MAPK-
dependent signaling alters mosquito biology in a manner
that benefits malaria parasite development.
Although P. falciparum does not encode a prototypical
p38 MAPK, the parasite genome does encode two MAPKs:
Pfmap-1 which is orthologous to ERK7/8 and Pfmap-2
which is not directly orthologous to any mammalian
MAPK subfamilies [81]. In addition, some p38 MAPK in-
hibitors have been shown to reduce the replication of asex-
ual stage P. falciparum [82]. Therefore, we sought to
confirm that the observed effects on oocyst development
in A. stephensi were due to inhibition of mosquito AsP38
MAPK signaling rather than inhibitor-induced alterations
of the intrinsic growth of the parasite. To this end, we
quantified DNA content over time as a measure of growth
of synchronized asexual P. falciparum parasites treated
with 1 and 10 μM SB203580 and BIRB796 in vitro. We
observed no significant effects on parasite growth following
treatment with either inhibitor (Fig. 4e). Although this
growth assay cannot be performed efficiently on mosquito-
stage parasites, we infer from these data that the infection
patterns observed in vivo using p38 MAPK inhibitors are
likely not due to direct negative effects on parasite develop-
ment in the mosquito. However, given the limitations of
our assay, we cannot rule out the possibility that these
inhibitors could interfere with ookinete development, para-
site migration through the epithelium, or the development
of oocysts and sporozoites.
Inhibition of AsP38 MAPK altered antimicrobial peptide
promoter activity in response to LPS or peptidoglycan
(PGN) stimulation in immortalized A. stephensi cells
Because p38 MAPK signaling is critical to innate im-
mune responses [83], we sought to determine the extent
to which AsP38 MAPK could regulate NF-κB-dependent
promoter activity in mosquito cells in vitro. We utilized
a luciferase-reporter assay to quantify the response of
mosquito cells in vitro to the bacterial PAMPs LPS and
peptidoglycan (PGN). ASE cells were stimulated with
either LPS or PGN and promoter activities of the NF-
Fig. 3 Inhibition of AsP38 MAPK reduced phosphorylation of MAPK-
activated kinase 2 (MK2) in vitro and in vivo. a Representative western
blot of phosphorylated MK2 (pMK2) from ASE cells pretreated with
10 μM SB203580 (SB), 10 μM BIRB796 (BIRB), or an equivalent volume
of DMSO as a control for 2 h and then stimulated with 1 μg/ml
LPS for 15 min. GAPDH provided an assessment of protein loading.
b Representative western blot of phosphorylated midgut MK2
(pMK2) from A. stephensi fed a P. falciparum-infected blood meal
supplemented with 10 μM SB203580 (SB), 10 μM BIRB796 (BIRB), or an
equivalent volume of DMSO; tissues were dissected at 2 h
post-feeding for analysis. Graph represents fold change ± SEMs of
pMK2 protein levels normalized to untreated controls, n = 3. Pairwise
comparisons of treatments versus controls at each time point were
analysed by Student’s t-test, significant p-values are shown
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κB-dependent antimicrobial peptide (AMP) genes Defen-
sin1, Cecropin1, and Gambicin were measured in the
presence of vehicle (DMSO) or following pre-treatment
with 0.1-10 μM of BIRB796 in DMSO. All three
promoter-reporters were induced by LPS and PGN as
previously described [7, 66, 68] (Fig. 5). As expected,
treatment with BIRB796 alone did not alter activity of the
Defensin1, Cecropin1, or Gambicin promoters in ASE cells
(Fig. 5). Further, although BIRB796 pre-treatment had no
effect on Gambicin promoter activity (Fig. 5, middle
panel), pre-treatment with 10 μM BIRB796 significantly
increased LPS- and PGN-dependent Cecropin1 promoter
activity (Fig. 5, top panel) and significantly decreased LPS-
dependent Defensin1 promoter activity (Fig. 5, bottom
panel), suggesting that the pattern of AsP38 MAPK regu-
lation of A. stephensi antimicrobial peptide expression in
vitro are gene- and stimulus-specific.
Inhibition of AsP38 MAPK increased parasite-inducible
expression of immune genes in the A. stephensi midgut
Our in vitro data indicated that AsP38 MAPK both posi-
tively and negatively regulated the expression of anti-
microbial peptide genes, suggesting that activation of
this pathway facilitates parasite development in vivo via
changes in anti-parasite effector genes. To test this
hypothesis, we used gene-specific primers to examine
midgut transcript expression levels of nitric oxide syn-
thase (NOS; ASTE008593), LRIM1 (ASTE000814), TEP1
Fig. 4 Inhibition of AsP38 MAPK signaling reduced P. falciparum development in A. stephensi. Mosquitoes were provided with a P. falciparum-infected
blood meal supplemented with (a, b) 0.1-10 μM SB203580 (SB) or (c, d) 10 μM BIRB796 (BIRB) or an equivalent volume of DMSO as a control. Midguts
were dissected and oocysts were counted at 10 days following infection. The experiment was replicated three times with separate cohorts of
mosquitoes and analysed by ANOVA to determine if the oocyst intensity in the controls differed amongst replicates. No difference was found, and the
data were pooled across replicates and analysed by Kruskal-Wallis to test for overall significance and Dunn's post-test for pairwise comparisons of
means. Significant p-values are shown for mean oocysts per infected midgut (zero values excluded). Prevalences of infection (mosquitoes with at least
one P. falciparum oocyst) are shown as percentages of dissected mosquitoes. Fisher's exact test was used to test for significance. (e) P. falciparum
cultures were incubated with 1 μM or 10 μM of SB203580 or BIRB796 or equivalent volume of DMSO as a control for 48 h. Graph represents average
relative growth compared to untreated controls (dotted line) at 48 h, n = 3. Pairwise comparisons of treatments versus control were analysed by
Student’s t-test. No significant differences among control and treatment groups were found
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(ASTE010227), APL1 (ASTEI02571), LRRD7/LRIM17
(ASTE009590) and Defensin1 (DEF1; ASTE011281), fol-
lowing blood meals containing P. falciparum freeze/thaw
parasite products (FTPP) in the presence or absence of
10 μM BIRB796 over the course of 24 h. Inhibition of
AsP38 MAPK activity induced the expression of almost all
anti-malarial effector genes at 6 h (only NOS and APL1
were marginally not significant), with a return to baseline
expression levels by 24 h after feeding (Fig. 6). In contrast,
DEF1 gene expression was decreased after AsP38 MAPK
inhibition, consistent with in vitro promoter activity
following LPS stimulation (Fig. 5). These data suggested
that AsP38 MAPK-dependent signaling negatively regu-
lates the activation of immune genes associated with para-
site killing, providing a potential mechanistic explanation
for the decrease in parasite development observed follow-
ing inhibition of MAPK activity (Fig. 4).
Inhibition of AsP38 MAPK decreased mosquito
antioxidant defenses
In addition to its role in the regulation of innate immun-
ity, p38 MAPK signaling can also affect stress responses
(reviewed in [84]). To understand these and the other
potential roles of AsP38 MAPK signaling on a more glo-
bal level, differential quantitative liquid chromatography/
tandem mass spectrometry (LC-MS/MS) was performed
to identify proteins that were over- or underrepresented
in A. stephensi fed P. falciparum-infected blood supple-
mented with 10 μM BIRB796 relative to age-matched,
female A. stephensi fed an identical infected blood meal
supplemented with an equivalent volume of DMSO as a
control. At 24 h post-feeding, 13 proteins out of a total
of 1,418 proteins were over-represented and 60 were un-
derrepresented following inhibition of AsP38 MAPK
(Table 1). These results suggested that AsP38 MAPK
promotes protein translation and synthesis as indicated
in the literature [45–48].
Among the underrepresented proteins, catalase and
SOD2 were significantly reduced by AsP38 MAPK inhib-
ition (Table 1). SOD2 is a mitochondrial manganese SOD
that dismutates superoxide anion into hydrogen peroxide
and diatomic oxygen; therefore, a reduction in SOD2
levels should result in increased midgut steady-state con-
centrations of mitochondrial superoxide. To test this hy-
pothesis, we estimated superoxide concentrations in
midgut mitochondria of female A. stephensi fed a saline
solution containing either 10 μM BIRB796 or a saline so-
lution with an equivalent volume of DMSO as a control.
At 6 h post-feeding, mitochondrial superoxide levels in
BIRB796-fed mosquitoes were significantly higher than
controls (Fig. 7a and 7b). Unmitigated oxidative stress has
also been associated with decreased short-term survivor-
ship in p38 MAPK mutants of D. melanogaster [38]. Ac-
cordingly, we tested whether reduced antioxidant defenses
Fig. 5 Inhibition of AsP38 MAPK altered antimicrobial peptide promoter activity in response to LPS or PGN stimulation in immortalized A.
stephensi cells. ASE cells were transfected with an antimicrobial peptide luciferase promoter-reporter plasmid construct and stimulated 24 h later
with 100 μg/ml LPS or 2 μg/ml PGN with 0.1 -10 μM BIRB796 or an equivalent volume of DMSO as a control. Graphs represent means ± SEMs of
luciferase activity (relative light units, RLU) normalized to untreated controls, n = 3-7. Cecropin1 (top, white) or Gambicin (middle, gray), or Defensin1
(bottom, black) promoter activities are indicated. Data were analysed by Student’s t-test and significant p-values are shown. NS = not significant
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(SOD2, catalase) could be associated with reduced mos-
quito survivorship in the context of oxidative stress via
feeding of a saline meal with 2 mM paraquat (an inducer
of superoxide anion production via redox cycling [85]) in
DMSO or with 2 mM paraquat and 10 μM BIRB. As ex-
pected, midgut peroxide levels relative to controls were in-
creased, albeit marginally significantly, by inhibition of
AsP38 MAPK (Fig. 7c). Inhibition of AsP38 MAPK also
resulted in significantly reduced survivorship to acute
paraquat challenge compared to the controls (Fig. 7d,
Table 2). Taken together, these results indicated that
AsP38 MAPK signaling likely enhances mosquito resist-
ance to oxidative stress and that inhibition of this MAPK
pathway significantly decreases ROS catabolism.
Increased mitochondrial ROS induced expression of
A. stephensi immune genes
In addition to the known ability of high levels of ROS to
directly kill malaria parasites [86, 87], moderate levels of
ROS can signal in the midgut to activate the mosquito
immune response [35, 41, 88]. Therefore, we reasoned
that the increase in anti-malarial effector gene expres-
sion observed following inhibition of AsP38 MAPK
(Fig. 6) could be due, in part, to increased mitochondrial
ROS (Fig. 7a and b). To assess the contribution of mito-
chondrial ROS to the activation of A. stephensi immune
genes, mosquitoes were fed a blood meal containing
1 μM rotenone, a concentration that can induce mito-
chondrial superoxide in the A. stephensi midgut to
approximately 2.5-fold that of control levels [89], con-
sistent with BIRB-induced superoxide levels (Fig. 7b). At
3 h post-feeding, midguts were collected for analysis of
anti-malarial immune gene expression by qRT-PCR.
Rotenone treatment alone significantly increased the ex-
pression of APL1 and LRRD7 with trends toward in-
creased TEP1 and LRIM1 expression relative to controls
(Fig. 8). However, no increased expression was detected
for NOS or DEF1 with rotenone treatment (Fig. 8), sug-
gesting that mitochondrial ROS contributes to, but does
not fully recapitulate, BIRB796-induced immune gene
expression in the A. stephensi midgut.
Inhibition of AsP38 MAPK decreased AsPGC-1 gene
expression and mitochondrial protein synthesis in
A. stephensi
Inhibition of AsP38 MAPK was associated with signifi-
cantly reduced levels of midgut mitochondrial proteins,
including NADH-ubiquinone oxidoreductase (Complex I),
succinate dehydrogenase (Complex II), cytochrome c
oxidase subunit VIIa (Complex IV), ATPase subunit
beta (Complex V), 3-hydroxybutyrate dehydrogenase
(ketone body metabolism), 3-ketoacyl-acyl carrier pro-
tein reductase (fatty acid biosynthesis/quinone reduc-
tase), putative mitochondrial inner membrane protein
as well as mitochondrial porin and kinesin heavy chain
orthologs (Table 1). This broad representation of struc-
tural, intermediary metabolism, and OXPHOS proteins
suggested that inhibition of AsP38 MAPK significantly
Fig. 6 Inhibition of AsP38 MAPK increased parasite-inducible expression of immune genes in the A. stephensi midgut. Graphs represent means ± SEMs
of fold change in the expression of selected immune genes in the midgut of mosquitoes fed a blood meal with P. falciparum freeze/thaw parasite
products (FTPP) supplemented with 10 μM BIRB796 or an identical FTPP meal supplemented with an equivalent volume of DMSO as a control. Pairwise
comparisons of treatments and matched controls were analysed by Student’s t-test; significant and marginally significant p-values are shown, n = 3-5
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Table 1 Proteins over- and under-represented in the A. stephensi midgut following inhibition of AsP38 MAPK signaling
Over-represented proteins following inhibition of AsP38 MAPK
Pathway or process Accession number Protein name UniProt gene name P value
Carbohydrate metabolism ASTEI05125 maltase 2 (mal2) MGAM 0.011
ASTEI02309 maltase MGAM 0.007
Cytoskeleton/development ASTEI01099 thymosin TMSNB 0.041
ASTEI03296 dynamin DNM 0.023
ASTEI04270 gelsolin GSN 0.036
ASTEI05229 collagen alpha-1 chain COLA1 0.008
ASTEI08311 myosin MYH 0.001
ASTEI11230 coracle CORA 0.001
Lysosomes ASTEI08520 v-type proton ATPase subunit c VATC 0.023
Mitochondria ASTEI11442 NADH dehydrogenase 1 beta subcomplex subunit 10 NDUFB10 0.020
ASTEI08224 60 kDa heat shock mitochondrial HSP60 0.006
Membrane fusion/exocytosis ASTEI07544 synaptosomal-associated protein 25 SNAP25 0.003
ASTEI07916 Nipsnap NIPSNAP1 0.008
Under-represented proteins following inhibition of AsP38 MAPK
Pathway or process Accession number Protein name UniProt gene name P value
Glycolysis ASTEI06800 hexokinase type 2 HK2 0.023
ASTEI05709 triosephosphate isomerase TPI1 0.019
ASTEI07469 pyruvate kinase PKM 0.009
Pentose phosphate shunt ASTEI07641 6-phosphogluconate dehydrogenase PGD 0.027
Fatty acid biosynthesis/quinone reductase ASTEI07966 3-ketoacyl-acyl carrier protein reductase FABG 0.009
Mitochondrial ketone body metabolism ASTEI05771 succinyl-ligase subunit SUCLA2 0.034
Mitochondrial OXPHOS ASTEI01282 succinate dehydrogenase iron-sulfur SDHB 0.052
ASTEI05686 NADH-ubiquinone oxidoreductase/75 kD NDUFS1 0.029
ASTEI10851 cytochrome c oxidase subunit vIIa COX7A1 0.034
ASTEI09954 ATPase subunit F ATP5F 0.004
ASTEI02184 3-hydroxybutyrate dehydrogenase HIBADH 0.047
Mitochondrial Krebs cycle ASTEI01282 succinate dehydrogenase iron-sulfur SDHB 0.052
Mitochondrial protein import/processing ASTEI04325 putative inner membrane protein IMMT 0.012
ASTEI06526 porin VDAC 0.005
Mitochondrial dynamics ASTEI08858 kinesin heavy chain KIF5B 0.009
Mitochondrial antioxidant defenses ASTEI07113 superoxide dismutase 2 SOD2 0.006
Ribosomes/translation ASTEI06447 40s ribosomal protein s16 RPS16 0.053
ASTEI09012 40s ribosomal protein s19a RPS19A 0.015
ASTEI08714 40s ribosomal protein s3 RPS3 0.017
ASTEI09336 40s ribosomal protein s3a RPS3A 0.021
ASTEI09193 40s ribosomal protein sa RPSA 0.006
ASTEI01139 60s ribosomal protein L10 RPL10 0.026
ASTEI04204 60s ribosomal protein L10a RPL10A 0.015
ASTEI00128 60s ribosomal protein L13 RPL13 0.028
ASTEI09035 60s ribosomal protein L15 RPL15 0.001
ASTEI01482 60s ribosomal protein L18 RPL18 0.053
ASTEI07898 60s ribosomal protein L23 RPL23 0.022
ASTEI08588 60s ribosomal protein L27a RPL27A 0.002
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impacted midgut mitochondrial mass, possibly through
inhibition of biogenesis. Further, given that p38 MAPK
regulation of PGC-1 orthologs from invertebrates to
mammals controls mitochondrial biogenesis, we hy-
pothesized that a reduction in A. stephensi PGC-1
(AsPGC-1) following inhibition of AsP38 MAPK could
account for these reductions in mitochondrial proteins.
To test this, we examined expression of AsPGC-1 in
mosquitoes fed P. falciparum-infected RBCs supplemented
with 10 μM BIRB796 relative A. stephensi fed an identical
infected blood meal supplemented with an equivalent
volume of DMSO as a control. Inhibition of AsP38
MAPK resulted in a significant decrease in AsPGC-1
gene expression relative to controls (Fig. 9), suggesting
that BIRB796 reductions in midgut mitochondrial pro-
teins in A. stephensi are associated with inhibition of
PGC-1 expression that is analogous to that observed in
other species.
Table 1 Proteins over- and under-represented in the A. stephensi midgut following inhibition of AsP38 MAPK signaling (Continued)
ASTEI05093 60s ribosomal protein L31 RPL31 0.020
ASTEI00059 60s ribosomal protein L36 RPL36 0.038
ASTEI00185 60s ribosomal protein L4 RPL4 0.007
ASTEI10247 60s ribosomal protein L5 RPL5 0.001
ASTEI01907 60s ribosomal protein L7 RPL7 0.010
ASTEI063681 heterogeneous nuclear ribonucleoprotein 40 HNRNPH1 0.034
ASTEI05590 polyadenylate-binding protein PABP 0.048
ASTEI08624 nascent polypeptide-associated complex subunit alpha NACA 0.027
ASTEI11090 signal recognition particle receptor, alpha homolog SRPR 0.033
ASTEI02606 eukaryotic translation initiation factor 3 subunit e EIF3E 0.038
ASTEI02686 eukaryotic translation initiation factor 3 subunit i EIF3I 0.039
ASTEI012841 RNA-binding protein 1 RBP1 0.005
ASTEI06323 ribosomal protein l14 RPL14 0.000
ASTEI06775 rRNA 2-o-methyltransferase fibrillarin FBL 0.022
ASTEI01829 cchc-type zinc finger protein ZCRB1 0.034
ASTEI10281 nipped-b protein NIPBL 0.017
Antioxidant/detoxification ASTEI10644 catalase CAT 0.022
ASTEI07113 superoxide dismutase 2 SOD2 0.006
ASTEI03473 aldehyde dehydrogenase family 7 member a1
homolog
ALDH7A1 0.003
ASTEI06895 cytochrome b5 CYB5 0.040
Proteolysis/lysosomes ASTEI07459 membrane alanyl aminopeptidase ANPEP 0.001
ASTEI09440 hypodermin c 0.045
ASTEI10033 chymotrypsin-2 CTRB1 0.008
ASTEI07899 proteasome subunit alpha type-1 PSMA1 0.039
ASTEI00715 endochitinase CHIT1 0.045
ASTEI10979 v-atpase subunit h ATP6V1H 0.047
ASTEI07458 aminopeptidase n ANPEP 0.027
ASTEI03577 acylsphingosine deacylase ASAH1 0.012
Endocytosis ASTEI09008 Ras-related protein Rab-18-b RAB18 0.017
ASTEI10979 v-atpase subunit h ATP6V1H 0.047
ASTEI03296 dynamin DNM 0.023
ASTEI01514 ocia domain-containing protein 1 OCIAD1 0.039
Iron storage ASTEI00707 ferritin heavy chain FTH1 0.031
Signal transduction ASTEI02790 guanine nucleotide-binding protein subunit beta-1 GNB1 0.003
ASTEI00708 protein ubash3a homolog UBASH3A 0.016
ASTEI05550 phosphatidylethanolamine-binding protein PEBP1 0.005
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AsP38 MAPK signaling regulates glycolysis and protein
translation in A. stephensi
Significantly decreased Complex I, II, IV and V sub-
units suggested that AsP38 MAPK inhibition would be
associated with reduced OXPHOS. In addition to
mitochondrial biogenesis, p38 MAPK signaling and
activation of PGC-1α and PGC-1β have also been
implicated in the control of glucose and lipid homeo-
stasis [54, 55, 57, 56]. In particular, PGC-1α is known
to drive expression of the gluconeogenic enzymes
PEPCK and G6Pase in liver, while PGC-1β enhances
fatty acid oxidation and glycolysis, principally through
the activation of glucokinase and PK. At 24 h following
provision of a P. falciparum-infected blood meal with
10 μM BIRB796, we noted that three proteins associated
with glycolysis were under-represented following inhib-
ition of AsP38 MAPK (Table 1), suggesting that these en-
zymes are positively regulated by AsP38 MAPK signaling.
Specifically, we observed decreased levels of hexokinase,
triosephosphate isomerase, and PK (Table 1). While these
changes indicate an impact on glycolysis, decreased levels
of nine key mitochondrial proteins (Table 1) suggest that
the main effects of AsP38 MAPK are due to modulation of
mitochondrial biogenesis/function (Table 1). In support of
Fig. 7 Inhibition of AsP38 MAPK in A. stephensi increased midgut ROS
levels and reduced mosquito survival. A. stephensi females were fed a
saline solution containing either 10 μM BIRB796 or an equivalent
volume of DMSO as a control and 10 midguts/group were collected 6 h
post-feeding. a Representative images from confocal microscopy of
MitoSOX Red stained midguts. Upper Panel: MitoSOX Red staining, scale
bars = 20 μm; Middle Panel: DAPI staining scale bars = 20 μm; Lower
Panel: Merged images, scale bars = 10 μm. b Graph of A. stephensi
midgut mitochondrial superoxide levels as determined by Mitosox Red
fluorescence staining. Data were analysed by Student’s t-test and are
represented as means ± SEM, p-value is shown, n= 4. c Graph of
midgut peroxide levels in A. stephensi fed with saline solution containing
2 mM paraquat with 10 μM BIRB796 or an equivalent volume of DMSO
as a control at 6 h post-feeding. Data were analysed by Student’s t-test
and represented as means ± SEM, p-value is shown, n= 3. d
Representative survivorship curve from Table 2 of A. stephensi fed a
saline solution with 1 mM paraquat supplemented with 10 μM BIRB796
or with an equivalent volume of DMSO as a control
Table 2 Inhibition of AsP38 MAPK under conditions of oxidative












1 28 24 0.004 0.026
2 28 24 0.015 0.007
3 32 24 0.025 0.052
Fig. 8 Mitochondrial ROS induced expression of A. stephensi
immune genes. Graph represents means ± SEMs of fold change in
the expression of selected immune genes in RNA samples prepared
from 30 pooled midguts of mosquitoes fed a blood meal containing
1 μM rotenone relative to mosquitoes fed an unsupplemented
blood meal (dotted line) at 6 h post-feeding. Data were analysed by
Student’s t-test, significant p-values are shown, n = 3
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this hypothesis, reduced glucose consumption and a shift
from OXPHOS to glycolysis were observed in midguts
from A. stephensi fed a P. falciparum-infected blood meal
supplemented with 10 μM BIRB796 compared to an identi-
cal infected blood meal supplemented with an equivalent
volume of DMSO as a control. Midgut pyruvate concentra-
tions were decreased at 48 and 72 h by supplementation
with BIRB796 (Fig. 10, top panel), whereas lactate concen-
trations were significantly increased at 72 h (Fig. 10, middle
panel). By adding pyruvate to lactate at each time point (as
an equivalent for total glucose utilization), it is clear that at
48 h there is a 1.7-fold increase in glucose consumption
upon ingestion of infected blood whereas with BIRB796, no
such increase occurs. A higher lactate-to-pyruvate ratio
(3.8-fold of controls; Fig. 10, bottom panel) in mosquitoes
fed an infectious blood meal containing BIRB796, confirms
that AsP38 MAPK is indeed involved in the regulation of
midgut glucose catabolism.
Following AsP38 MAPK inhibition, we also noted a
significant under-representation of proteins involved
in the processes of protein translation and synthesis
such as eukaryotic initiation factor (eIF)-3E and -3I, as
well a number of ribosomal and RNA-binding proteins
(Table 1). Activation of p38 MAPK has been associ-
ated with increased protein translation via signaling
through MK2, which enhances mRNA stability and
translation [47, 90]. Therefore, the loss of midgut
MK2 phosphorylation following inhibition of AsP38
MAPK (Fig. 3) likely accounts for the observed
decrease in protein translation machinery (Table 1).
Collectively, our inferences regarding proteins in Table 1
were supported by hypergeometric algorithm analysis
followed by Benjamini-Hochberg correction for overrepre-
sentation of pathways (Table 3). This analysis indicated
that the most affected pathways were those associated
with protein translation (ribosome, RNA transport and
degradation), glucose catabolism (OXPHOS, TCA cycle,
Fig. 9 Inhibition of AsP38 MAPK decreased AsPGC-1 gene expression
in the A. stephensi midgut. Mosquitoes were fed with P. falciparum-
infected RBCs supplemented with 10 μM BIRB796 (BIRB) or an
equivalent volume of DMSO as a control (dotted line). Graph
represents means ± SEMs of fold change in the expression of AsPGC-1
in RNA prepared from 30 pooled mosquito midguts, n = 5. Data were
analysed by Student’s t-test; significant p-values are shown
Fig. 10 Inhibition of AsP38 MAPK altered pyruvate and lactate
concentrations in the A. stephensi midgut. A. stephensi were fed a P.
falciparum-infected blood meal supplemented with either 10 μM
BIRB796 or an equivalent volume of DMSO and 300 midguts/group
were collected at 0, 48, and 72 h post-feeding to determine pyruvate
and lactate levels. Graphs represent means ± SEMs of 3 independent
measurements. Statistical analysis was performed by one-way ANOVA,
followed by Bonferroni’s post-test for multiple comparisons between
treatments (BIRB796) and controls (DMSO); significant p-values are shown
Wang et al. Parasites & Vectors  (2015) 8:424 Page 15 of 21
pyruvate metabolism, glycolysis), and infection (epithelial
response and phagocytosis).
Discussion
P38 MAPK is an evolutionarily conserved signaling
protein with critical activity for innate immunity, inter-
mediary metabolism, and mitochondrial function. In
mammals, PAMP induction of Toll-like receptor (TLR)
signaling activates p38 MAPK, JNK, and NF-κB-
dependent transcription for the generation of distinct
pro-inflammatory cytokines and cellular responses [91]. In
Drosophila, p38 MAPK contributes to the regulation of
the immune effectors through the Toll- or immune defi-
cient (IMD)-independent pathways [19]. In C. elegans,
vestiges of insect and mammalian Toll/TLR signaling are
evident, but the nematode genome does not encode
orthologs of MyD88, NF-κB, or IMD, suggesting that p38
MAPK signaling predates involvement of NF-κB in im-
munity [21]. However, p38 MAPK does not always posi-
tively regulate immune effector genes, but rather seems to
modulate the quality and quantity of these effectors. In
p38b mutant D. melanogaster, some genes encoding im-
mune effectors and AMPs were up-regulated while some
were down-regulated [20]. Our data suggested similar
complexity in that AsP38 MAPK positively regulated
Defensin1 gene promoter activity under LPS stimulation,
negatively regulated Cec gene promoter activity for both
LPS and PGN stimulation, and did not alter the regulation
Table 3 Over-represented pathways in the A. stephensi midgut upon BIRB796-mediated inhibition of AsP38 MAPK




Pathway p-value Pathway p-value
(corrected)
Gene symbols
Ribosome 474 17 87 2.89E-23 1.53E-22 RPL10; RPL10A; RPL13; RPL14;
RPL15; RPL18; RPL23; RPL27A;
RPL31; RPL4; RPL5; RPL7; RPS16;
RPS19; RPS3; RPS3A; RPSA
Oxidative
phosphorylation




414 4 64 3.51E-04 0.001 ALDH7A1; HK2; PKM2; TPI1
Metabolic pathways 4373 15 1115 4.20E-04 0.001 ALDH7A1; ANPEP; ASAH1;
ATP6V1C1; ATP6V1H; HIBADH;
HK2; MGAM; NDUFB10; NDUFS1;
PGD; PKM2; SDHB; SUCLA2; TPI1
Galactose metabolism 407 2 27 0.009 0.021 HK2; MGAM
Citrate cycle (TCA cycle) 464 2 30 0.011 0.021 SDHB; SUCLA2
Propanoate metabolism 472 2 32 0.012 0.023 ALDH7A1; SUCLA2
Fructose and mannose
metabolism
548 2 35 0.015 0.025 HK2; TPI1
Carbohydrate digestion
and absorption
10389 2 41 0.020 0.031 HK2; MGAM
Pyruvate metabolism 450 2 40 0.019 0.031 ALDH7A1; PKM2
Valine, leucine and
isoleucine degradation




466 2 48 0.027 0.035 CHIT1; HK2
Glutathione
metabolism
534 2 48 0.027 0.035 ANPEP; PGD
Starch and sucrose
metabolism
536 2 49 0.028 0.036 HK2; MGAM
Epithelial cell signaling
in infection
420 2 54 0.033 0.040 ATP6V1C1; ATP6V1H
RNA transport 10361 3 149 0.044 0.052 EIF3E; EIF3I; PABPC1
RNA degradation 5710 2 68 0.050 0.056 HSPD1; PABPC1
Lysosome 4356 2 121 0.135 0.143 ASAH1; ATP6V1H
Phagosome 10394 2 145 0.180 0.187 ATP6V1C1; ATP6V1H
aData from Table 1 were utilized to run a hypergeometric algorithm following a Benjamini-Hochberg correction for significance. Pathways not relevant to
mosquito metabolism were deleted from the analysis
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of Gam promoter activity under either immune stimulus
in haemocyte-like ASE cells in vitro (Fig. 5). In the midgut
epithelium, AsP38 MAPK negatively regulated a suite of
known anti-parasite effector genes to varying degrees, but
positively regulated DEF1 gene expression in the same tis-
sue (Fig. 6). Our results are consistent with p38 MAPK
regulation of Def in A. aegypti [23] and for Cec in Aedes
albopictus and D. melanogaster [20, 25].
In addition to immunity, p38 MAPK signaling is central
to metabolic regulation and redox homeostasis. In this con-
text, the principal mediators in mammals include PGC-1α
and PGC-1β. In particular, activated p38 MAPK regulates
expression of PGC-1 orthologs and can also directly
phosphorylate substrates to modulate protein stability and
activity [92–95]. Our data showed that p38 MAPK inhib-
ition reduced PGC-1 midgut transcript levels in P. falcip-
arum-infected A. stephensi (Fig. 9), which together with
our biochemical and proteomics data (Fig. 10, Table 1),
suggest that AsP38 MAPK-dependent regulation of PGC-
1 controls midgut glucose utilization via mitochondria. In
mammalian liver, PGC-1α and PGC-1β coordinately regu-
late gluconeogenesis and glycolysis in response to different
stimuli (reviewed in [49]), and are largely redundant in the
regulation of mitochondrial oxidative metabolism through
coactivation of the peroxisome proliferator-activated re-
ceptors [50, 51], oestrogen-related receptors [52], and nu-
clear respiratory factors [53]. Intriguingly, however, the
biological role of the relatively more ancient mammalian
PGC-1β [95] appears to be reflected in A. stephensi. That
is, inhibition of AsP38 MAPK downregulated midgut gly-
colysis and, more so, OXPHOS as judged by a decrease in
hexokinase and PK proteins at 24 h post-treatment that
was followed by a decrease in pyruvate by 48 h and an in-
crease in lactate from pyruvate by 72 h (Fig. 10). In another
context, PGC-1β control of mammalian NF-κB expression
and activity suggests that a similar metabolic-immune sig-
naling axis is mediated by PGC-1 that complements mito-
chondrial ATP and ROS-mediated gene activation in the A.
stephensi midgut (Fig. 8).
Inhibition of AsP38 MAPK resulted in increased levels
of midgut mitochondrial superoxide and stress-induced
peroxide at 6 h following provision of BIRB796 in a sa-
line meal (Fig. 7a, b and c) that are likely sustained
through at least 24 h following P. falciparum infection
by reduced levels of SOD2 and catalase (Table 1). This
increase in steady-state concentrations of midgut ROS
that cannot be mitigated by endogenous antioxidants
likely contributes to reduced short-term survivorship of
A. stephensi relative to controls (Fig. 7d). Similar obser-
vations in both mammals and in D. melanogaster sug-
gest that p38 MAPK regulation of antioxidants is critical
for cellular response to oxidative stress. In particular,
inhibition of p38α in mouse embryonic fibroblasts led to
ROS accumulation upon exposure to hydrogen peroxide,
significantly increasing cell death that could be rescued
with antioxidant treatment [40]. In D. melanogaster, p38b
and p38a/b double mutants exhibited significantly de-
creased short-term survival to continuous feeding with
hydrogen peroxide compared to wild type controls [38].
Further, the more extensive effects of shortened lifespans
observed in p38b mutants and p38a/b double mutants
could be rescued by overexpression of p38b [38], suggesting
that p38 MAPK-dependent signaling is critical for both
short-term protection against oxidative stress and longer
term survival. Intriguingly, PGC-1α is required for the in-
duction of antioxidants (SOD1, SOD2, catalase, GPx1) to
suppress ROS levels in mice in vivo and in murine neuronal
cells in vitro [96], suggesting that a lack of PGC-1 activity
in fruit flies and mosquitoes could also explain the effects
of p38 MAPK inhibition on sensitivity to oxidative stress.
Bacteria present in the midgut have been shown to
modulate the mosquito immune response through activa-
tion of basal immunity and in the absence of midgut flora
Anopheles mosquitoes are more susceptible to Plasmodium
infection [97]. Although blood feeding leads to a bloom of
gut microflora in Anopheles [98–100], it also concurrently
reduces the diversity of the gut bacterial community dra-
matically [100]. Therefore, while it is likely that midgut bac-
teria contribute to p38 MAPK activation during blood
feeding, our data suggest that this effect is altered by the
presence of malaria parasites. In particular, we have shown
that there are no significant differences in midgut bacteria
CFUs in mosquitoes fed uninfected versus Plasmodium-in-
fected blood either at 24 or 48 h post feeding (Additional
file 2). Therefore, we can infer that the contribution of bac-
teria and endotoxin to the observed changes in AsP38
MAPK signaling are consistent between mosquitoes fed
uninfected and infected blood. As such, any differences ob-
served in mosquitoes fed an infectious blood meal are due
to the presence of parasites and not to quantitative
alterations in midgut flora. Interestingly, infected RBCs
have been shown to contain endotoxin-like lipidic
molecules [101] and could, therefore, activate p38 MAPK
signaling via pathways that are similar to those activated by
bacterial endotoxin.
In mammals, p38 MAPK activation has been associ-
ated with increased mRNA translation via phosphoryl-
ation of MK2, which enhances mRNA stability and
translation [47, 90]. Inhibition of AsP38 MAPK was as-
sociated with reduced phosphorylation of MK2 in ASE
cells and in the midgut epithelium (Fig. 3) and with sig-
nificantly reduced levels of proteins associated with
mRNA translation in the same tissue at 24 h post-
treatment (Table 1). A previous study reported signifi-
cantly enhanced translation of midgut mRNAs during
the first 22-26 h following P. falciparum infection in A.
gambiae with notably few changes in mRNAs for im-
mune genes [102], suggesting that parasite-induced
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activation of p38 MAPK signaling in the midgut epithe-
lium of both important malaria vectors regulates a con-
served response to infection. Alternatively, compromised
ATP status emerging from lower glucose catabolism can
also decrease the high-energy consuming process of syn-
thesizing ribosomal RNAs. Based on data from Fig. 10,
the ATP generated following treatment with BIRB796
can be estimated as 44 % of controls, conditions akin to
starvation that may also decrease protein synthesis as
evidenced by the 5-fold ratio of underrepresented/over-
represented proteins (Table 1).
Conclusions
In this study, we used small molecule inhibitors as tools to
probe the significance of parasite infection-induced AsP38
MAPK phosphorylation and infer that this activation
induces PGC-1 expression, which contributes to increased
glycolysis, mitochondrial biogenesis, and synthesis of
antioxidant enzymes. Further, AsP38 MAPK activation
enhances MK2 phosphorylation and, as interpreted from
BIRB796 inhibition, mRNA translation in the midgut epi-
thelium, events that are likely to be functionally con-
nected. Hence, parasite-mediated activation of p38 MAPK
signaling in the A. stephensi midgut likely protects the
host from oxidative stress and enhances survivorship, but
also decreases the activation of energetically costly anti-
parasite gene expression. Increased glycolysis, OXPHOS
and mRNA translation can mitigate energy loss and cel-
lular damage due to infection (Fig. 11), suggesting that
AsP38 MAPK signaling contributes to mosquito sur-
vival during P. falciparum infection.
Our data have revealed that p38 MAPK activation during
P. falciparum infection of A. stephensi is associated with en-
hanced fitness – as defined by increased protein synthesis,
mitochondrial biogenesis, and resistance to oxidative
stress– and a reduced innate immune response to infection.
Given that insecticide resistance has been associated with
enhanced mitochondrial metabolism (Complexes I and IV;
[103]) and antioxidant levels (GST, TPX2; [103, 104]), gen-
etic or pharmacological strategies to inhibit p38 MAPK sig-
naling in natural populations of mosquitoes could decrease
malaria parasite infection prevalence and enhance acute
susceptibility to chemical pesticides. Together with our pre-
vious work [63], these data provide additional evidence for
networked regulation of mitochondrial metabolism, anti-
oxidant response and immunity in A. stephensi, which can
be leveraged for improved methods for malaria transmis-
sion control.
Additional files
Additional file 1: P. falciparum parasite products (PfPs) induced AsP38
MAPK phosphorylation in vitro relative to control. (TIFF 1850 kb)
Additional file 2: P. falciparum-infected RBCs did not significantly alter
midgut bacterial growth relative to uninfected RBCs. (TIFF 2079 kb)
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transcription factors that drive expression of proteins involved in
glycolysis, mitochondrial biogenesis, and protein translation, which
results in enhanced energy efficiency and protein synthesis. Activation
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development and transmission
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